DNDN

Dendreon Corporation News Headlines

$3.94
*  
0.07
  negative  
1.75%
Get DNDN Alerts
*Delayed - data as of May 20, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Largest option buying in equities so far
12/15/2011 12:21:05 PM - optionMONSTER

2012 Preview: Cancer Immunotherapy Catalysts
12/15/2011 11:17:00 AM - Seeking Alpha

Trader positions for Dendreon downside
12/15/2011 11:08:43 AM - optionMONSTER

Dendreon: NeoACT Phase 2 Trial Data Appear 'Interesting'
12/12/2011 11:23:00 AM - Seeking Alpha

An Update On 7 Potential Big Movers
12/12/2011 4:31:00 AM - Seeking Alpha

20 Biotech Stocks That Hedge Funds Are Selling
12/11/2011 2:13:00 AM - Seeking Alpha

Zacks Bull and Bear of the Day Highlights: SIRIUS XM Radio, Meritor, Dendreon, Merck and Roche - Press Releases
12/9/2011 9:30:01 AM - Zacks.com

Dendreon to Sell Victrelis Rights - Analyst Blog
12/8/2011 2:00:01 PM - Zacks.com

The Recent Performance Of George Soros's Largest Equity Holdings
12/8/2011 5:53:00 AM - Seeking Alpha

NeoStem Might Be A Hidden Gem
12/7/2011 12:23:00 PM - Seeking Alpha

4 Biotech Stocks To Buy, 1 To Avoid
12/6/2011 4:04:00 AM - Seeking Alpha

7 Stocks Experiencing Large Downward Earnings Revisions
12/5/2011 8:26:00 PM - Seeking Alpha

10 Buyout Candidates To Watch
11/28/2011 10:02:00 AM - Seeking Alpha

7 Biggest Stock Disappointments Of 2011
11/28/2011 4:39:00 AM - Seeking Alpha

Dendreon faces range-bound strategy
11/23/2011 1:27:33 PM - optionMONSTER

Largest option buying in equities so far
11/23/2011 12:20:43 PM - optionMONSTER

Risk-Reward Balanced at Dendreon - Analyst Blog
11/23/2011 12:15:01 PM - Zacks.com

The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune and Dendreon - Press Releases
11/22/2011 9:30:01 AM - Zacks.com

Biotech Investing Lessons: GILD Buys VRUS - Tactical Trading
11/21/2011 1:00:01 AM - Zacks.com

Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
11/18/2011 11:19:00 AM - Seeking Alpha

Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA Capital
11/18/2011 10:15:00 AM - Seeking Alpha

How To Trade Antares And Dendreon's Whimsical Pop
11/17/2011 2:07:00 PM - Seeking Alpha

IPO Preview: NewLink Genetics
11/8/2011 5:31:00 PM - Seeking Alpha

5 Drugs That Own The Prostate Pipeline
11/8/2011 2:21:00 AM - Seeking Alpha

A Cautionary Tale
11/1/2011 6:54:07 PM - Ted Allrich